Kürşat Karadayı
About
In The Last Decade
Kürşat Karadayı
48 papers receiving 538 citations
Peers
Comparison fields: 5 of 88
- Surgery 295
- Pathology and Forensic Medicine 98
- Pulmonary and Respiratory Medicine 96
- Molecular Biology 65
- Oncology 55
Countries citing papers authored by Kürşat Karadayı
This map shows the geographic impact of Kürşat Karadayı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kürşat Karadayı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kürşat Karadayı more than expected).
Fields of papers citing papers by Kürşat Karadayı
This network shows the impact of papers produced by Kürşat Karadayı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kürşat Karadayı. The network helps show where Kürşat Karadayı may publish in the future.
Co-authorship network of co-authors of Kürşat Karadayı
This figure shows the co-authorship network connecting the top 25 collaborators of Kürşat Karadayı. A scholar is included among the top collaborators of Kürşat Karadayı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kürşat Karadayı. Kürşat Karadayı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 4 | |
| 5 | 4 | |
| 6 | 3 | |
| 7 | 15 | |
| 8 | 1 | |
| 9 | 25 | |
| 10 | 10 | |
| 11 | 41 | |
| 12 | 4 | |
| 13 | 1 | |
| 14 | 7 | |
| 15 | 17 | |
| 16 | Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance. | 8 |
| 17 | 10 | |
| 18 | 23 | |
| 19 | 69 | |
| 20 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.